Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B0ZM
|
||||
Former ID |
DNC010566
|
||||
Drug Name |
N,N-Dipropyl-1'H-phenothiazine-1'-carboxamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C19H22N2OS
|
||||
Canonical SMILES |
CCCN(CCC)C(=O)N1C2=CC=CC=C2SC3=CC=CC=C31
|
||||
InChI |
1S/C19H22N2OS/c1-3-13-20(14-4-2)19(22)21-15-9-5-7-11-17(15)23-18-12-8-6-10-16(18)21/h5-12H,3-4,13-14H2,1-2H3
|
||||
InChIKey |
VELWLEWVSKZOLN-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cholinesterase | Target Info | Inhibitor | [1] | |
PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathway | |||||
WikiPathways | Irinotecan Pathway | ||||
References | |||||
REF 1 | Bioorg Med Chem. 2010 Mar 15;18(6):2232-44. Epub 2010 Feb 4.Differential binding of phenothiazine urea derivatives to wild-type human cholinesterases and butyrylcholinesterase mutants. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.